4EB3 image
Deposition Date 2012-03-23
Release Date 2013-02-06
Last Version Date 2023-09-13
Entry Detail
PDB ID:
4EB3
Keywords:
Title:
Crystal structure of IspH in complex with iso-HMBPP
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:4-hydroxy-3-methylbut-2-enyl diphosphate reductase
Gene (Uniprot):ispH
Chain IDs:A, B
Chain Length:327
Number of Molecules:2
Biological Source:Escherichia coli
Primary Citation
Are free radicals involved in IspH catalysis? An EPR and crystallographic investigation.
J.Am.Chem.Soc. 134 11225 11234 (2012)
PMID: 22687151 DOI: 10.1021/ja303445z

Abstact

The [4Fe-4S] protein IspH in the methylerythritol phosphate isoprenoid biosynthesis pathway is an important anti-infective drug target, but its mechanism of action is still the subject of debate. Here, by using electron paramagnetic resonance (EPR) spectroscopy and (2)H, (17)O, and (57)Fe isotopic labeling, we have characterized and assigned two key reaction intermediates in IspH catalysis. The results are consistent with the bioorganometallic mechanism proposed earlier, and the mechanism is proposed to have similarities to that of ferredoxin, thioredoxin reductase, in that one electron is transferred to the [4Fe-4S](2+) cluster, which then performs a formal two-electron reduction of its substrate, generating an oxidized high potential iron-sulfur protein (HiPIP)-like intermediate. The two paramagnetic reaction intermediates observed correspond to the two intermediates proposed in the bioorganometallic mechanism: the early π-complex in which the substrate's 3-CH(2)OH group has rotated away from the reduced iron-sulfur cluster, and the next, η(3)-allyl complex formed after dehydroxylation. No free radical intermediates are observed, and the two paramagnetic intermediates observed do not fit in a Birch reduction-like or ferraoxetane mechanism. Additionally, we show by using EPR spectroscopy and X-ray crystallography that two substrate analogues (4 and 5) follow the same reaction mechanism.

Legend

Protein

Chemical

Disease

Primary Citation of related structures